Innovative radiotherapy approaches

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Concurrent chemoradiotherapy is standard for anal canal squamous-cell carcinoma (SCCAC), yielding good local control and survival.
• Intensity-modulated radiotherapy (IMRT) improves toxicity but has limitations, with persistent severe side effects impacting quality of life.
• Locoregional failure remains a challenge in SCCAC treatment despite current standards.

Purpose of the Study:

• To review strategies for enhancing radiotherapy (RT) outcomes in anal cancer.
• To explore novel RT techniques for improving efficacy and reducing toxicity in SCCAC treatment.
• To discuss the integration of advanced RT technologies for personalized anal cancer therapy.

Main Methods:

• Review of current literature on advanced radiotherapy techniques for anal cancer.
• Examination of risk-adapted target delineation and daily target volume adjustment.
• Evaluation of brachytherapy, MRI-Linac, and proton therapy for anal cancer treatment.

Main Results:

• Risk-adapted delineation may personalize treatment volumes, enhancing efficacy and safety.
• Brachytherapy offers dose escalation with reduced toxicity through image-guided techniques.
• Proton therapy and advanced modalities like MRI-Linac show potential for reduced toxicity and improved outcomes by adapting to anatomical changes.

Conclusions:

• Advanced RT strategies including risk-adapted delineation, brachytherapy, proton therapy, and MRI-Linac offer potential to optimize therapeutic ratios in anal cancer.
• Personalized dose adjustments and accounting for daily variations are key to minimizing toxicity and improving patient outcomes.
• Ongoing trials investigating dose-volume stratification, adaptive treatment, and proton therapy are crucial for further optimizing RT for SCCAC.